Soligenix Inc. – October 28, 2005 Confidential Kind Attn: Hans T. Schambye, PhD Chief Executive Officer Gastrotech Pharma A/S Nyhavn 43B Copenhagen 1051 Denmark Dear Hans: I Am Pleased to Submit This Binding Letter of Intent (The "Binding LOI") to Gastrotech Pharma A/S ("Gastrotech") to Acquire 100% of the Fully Diluted Shares Outstanding1 of Gastrotech (The "Shares"). This Transaction, as Defined Hereunder, Has Been Approved by the Board of Directors of Both Companies, the Shareholders of Gastrotech, and Is Subject to the Approval of the Shareholders of DOR. Subject to Fiduciary Duty Principles, the Board of (November 2nd, 2005)
This letter and all the information contained herein are confidential and may not be disclosed to any third party for any purpose, and are subject to the terms of the confidentiality agreement entered into between DOR and Gastrotech (separately the "Party" or collectively the "Parties").
Soligenix Inc. – Employment Agreement (December 14th, 2004)
This Agreement (the Agreement), dated as of December 7, 2004 (the Effective Date) by and between DOR BioPharma, Inc., a Delaware corporation having a place of business at 1691 Michigan Avenue Suite 435, Miami, FL 33139 (the Corporation), and Michael Sember, an individual (the Employee).